CyclosporineLiver TransplantationTransplantation, HomologousKidney TransplantationImmunosuppressive AgentsBone Marrow TransplantationHeart TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousLung TransplantationGraft RejectionGraft SurvivalStem Cell TransplantationTransplantation ConditioningOrgan TransplantationTacrolimusTissue DonorsPancreas TransplantationTransplantationTransplantation ImmunologyIslets of Langerhans TransplantationGraft vs Host DiseaseCell TransplantationTransplantation ChimeraTreatment OutcomeImmunosuppressionLiving DonorsTransplantation, IsogeneicTransplantation, HeterotopicMycophenolic AcidHeart-Lung TransplantationTime FactorsCord Blood Stem Cell TransplantationRetrospective StudiesHistocompatibility TestingTransplantation ToleranceLiver FailurePeripheral Blood Stem Cell TransplantationRecurrenceTissue and Organ ProcurementPostoperative ComplicationsSkin TransplantationFetal Tissue TransplantationHistocompatibilityAzathioprineCalcineurinHematologic NeoplasmsFollow-Up StudiesWhole-Body IrradiationAntilymphocyte SerumAnemia, AplasticTransplantation, HeterologousCorneal TransplantationCadaverWaiting ListsSurvival AnalysisSurvival RateMesenchymal Stem Cell TransplantationKidneyDrug Therapy, CombinationTissue TransplantationSirolimusRats, Inbred LewCyclophilin ALiver DiseasesPrednisoneKidney Failure, ChronicBusulfanLeukemiaAcute DiseaseBrain Tissue TransplantationHLA AntigensKidney DiseasesFacial TransplantationDonor SelectionRisk FactorsProspective StudiesRemission InductionOrgan PreservationMethylprednisolonePostoperative PeriodBronchiolitis ObliteransCyclophosphamideCombined Modality TherapyLiverCreatinineTransplantsPrednisoloneT-LymphocytesDrug MonitoringMyeloablative AgonistsBiopsyCytomegalovirus InfectionsMice, Inbred C57BLInfectionPrognosisDisease-Free SurvivalNephrotic SyndromeHand TransplantationBlood Group Incompatibility